JP2006063040A - 高浸透性を有する生理活性水の製造法 - Google Patents
高浸透性を有する生理活性水の製造法 Download PDFInfo
- Publication number
- JP2006063040A JP2006063040A JP2004249522A JP2004249522A JP2006063040A JP 2006063040 A JP2006063040 A JP 2006063040A JP 2004249522 A JP2004249522 A JP 2004249522A JP 2004249522 A JP2004249522 A JP 2004249522A JP 2006063040 A JP2006063040 A JP 2006063040A
- Authority
- JP
- Japan
- Prior art keywords
- water
- organic germanium
- nanocluster
- porous glass
- organogermanium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 151
- 230000035699 permeability Effects 0.000 title claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 239000005373 porous glass Substances 0.000 claims abstract description 21
- 239000011148 porous material Substances 0.000 claims abstract description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 12
- 239000001257 hydrogen Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 48
- 229910052732 germanium Inorganic materials 0.000 claims description 44
- 230000001954 sterilising effect Effects 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 238000004659 sterilization and disinfection Methods 0.000 claims description 16
- 230000000975 bioactive effect Effects 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 11
- 230000001766 physiological effect Effects 0.000 claims description 3
- 125000000082 organogermanium group Chemical group 0.000 abstract description 15
- 239000007864 aqueous solution Substances 0.000 abstract description 6
- 239000012530 fluid Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 abstract description 3
- 238000004220 aggregation Methods 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000035622 drinking Effects 0.000 description 22
- 229910052760 oxygen Inorganic materials 0.000 description 17
- 239000001301 oxygen Substances 0.000 description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 12
- -1 put into a reactor Chemical compound 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 229910001220 stainless steel Inorganic materials 0.000 description 9
- 239000010935 stainless steel Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- VEVYSMQHEYUIDQ-UHFFFAOYSA-N carboxy(ethyl)germanium Chemical compound CC[Ge]C(O)=O VEVYSMQHEYUIDQ-UHFFFAOYSA-N 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 208000005176 Hepatitis C Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000001994 activation Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 208000006154 Chronic hepatitis C Diseases 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 208000010710 hepatitis C virus infection Diseases 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004381 amniotic fluid Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000002291 germanium compounds Chemical class 0.000 description 2
- 239000003673 groundwater Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010019791 Hepatitis post transfusion Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000002619 cancer immunotherapy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229940093626 germanium sesquioxide Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Heat Treatment Of Water, Waste Water Or Sewage (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
凝集する水分子の数が少なく、羊水や脳水のような人体の体液とほぼ等しい集合構造の生理活性水を製造し、通常の有機ゲルマニウム水溶液に比べて浸透性がより高く、体内への吸収性が非常に高いことで有機ゲルマニウムの効能をいっそう有効に活用する。
【解決手段】
水分子が水素結合によって凝集して大きい集合体となっている通常の原料水を用い、孔径0.1〜20μmである多孔質ガラスフィルターを複数回通して、水分子の集合体からほぼ均一のナノクラスター水を得るとともに除菌フィルターを通し、さらに水との親和性および生理活性を有する有機ゲルマニウムの粉末を添加して溶解させる。
【選択図】図1
Description
図3 被験者:男性(50才)、(1)飲用前、(2)150cc飲用後6分
図4 被験者:男性(52才)、(1)飲用前、(2)150cc飲用後10分
図5 被験者:男性(62才)、(1)飲用前、(2)200cc飲用後20分
図6 被験者:女性(47才)、(1)飲用前、(2)150cc飲用後10分
図7 被験者:女性(63才)、(1)飲用前、(2)150cc飲用後12分
図8 被験者:女性(69才)、(1)飲用前、(2)150cc飲用後5分
図9 被験者:女性(74才)、(1)飲用前、(2)200cc飲用後20分
2 固形物除去工程
3 第2除菌工程
5 1次クラスター化工程
6 第3除菌工程
7 生理活性化工程
8 殺菌工程
10 再クラスター化工程
Claims (3)
- 水分子が水素結合によって凝集して大きい集合体となっている通常の原料水を用い、孔径0.1〜20μmである多孔質ガラスフィルターを複数回通して、水分子の集合体からほぼ均一のナノクラスター水を得るとともに除菌フィルターを通し、さらに水との親和性および生理活性を有する有機ゲルマニウムの粉末を添加して溶解させることにより、有機ゲルマニウムのイオン化によってナノクラスター水が再凝集することを防止して安定化させる高浸透性を有する生理活性水の製造法。
- 原料水を孔径0.1〜20μmである多孔質ガラスフィルターで2回濾過してから、クッションタンクにおいて有機ゲルマニウムの結晶性粉末を混入して溶解させる請求項1記載の製造法。
- 有機ゲルマニウムの結晶性粉末を添加して溶解させ、プレート式熱交換機によって加熱殺菌した後に、さらに孔径0.1〜20μmである多孔質ガラスフィルターを通す請求項1記載の製造法。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004249522A JP2006063040A (ja) | 2004-08-30 | 2004-08-30 | 高浸透性を有する生理活性水の製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004249522A JP2006063040A (ja) | 2004-08-30 | 2004-08-30 | 高浸透性を有する生理活性水の製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006063040A true JP2006063040A (ja) | 2006-03-09 |
Family
ID=36109822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004249522A Pending JP2006063040A (ja) | 2004-08-30 | 2004-08-30 | 高浸透性を有する生理活性水の製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006063040A (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006110535A (ja) * | 2004-10-15 | 2006-04-27 | Spg Techno Kk | 多孔質ガラスを用いた界面活性力を有する水又は水溶液の生成方法とその装置 |
| JP2008238157A (ja) * | 2007-03-28 | 2008-10-09 | Waters Co Ltd | 有機ゲルマニウムを含む浄水器用フィルター及びそのフィルターの製造方法 |
| CN101891328A (zh) * | 2010-08-12 | 2010-11-24 | 郑兆歌 | 一种天然的永恒的弱碱性小分子团水的制作设备及其方法 |
| JP2013048564A (ja) * | 2011-08-30 | 2013-03-14 | Leda Co Ltd | プラセンタエキスの抽出方法および栄養補給サプリメント |
| CN106219721A (zh) * | 2016-08-19 | 2016-12-14 | 胡巍 | 一种高含氢量的饮用水的制备方法 |
-
2004
- 2004-08-30 JP JP2004249522A patent/JP2006063040A/ja active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006110535A (ja) * | 2004-10-15 | 2006-04-27 | Spg Techno Kk | 多孔質ガラスを用いた界面活性力を有する水又は水溶液の生成方法とその装置 |
| JP2008238157A (ja) * | 2007-03-28 | 2008-10-09 | Waters Co Ltd | 有機ゲルマニウムを含む浄水器用フィルター及びそのフィルターの製造方法 |
| CN101891328A (zh) * | 2010-08-12 | 2010-11-24 | 郑兆歌 | 一种天然的永恒的弱碱性小分子团水的制作设备及其方法 |
| WO2012019569A1 (zh) * | 2010-08-12 | 2012-02-16 | Zheng Zhaoge | 一种天然的永恒的弱碱性小分子团水的制作设备及其方法 |
| JP2013048564A (ja) * | 2011-08-30 | 2013-03-14 | Leda Co Ltd | プラセンタエキスの抽出方法および栄養補給サプリメント |
| CN106219721A (zh) * | 2016-08-19 | 2016-12-14 | 胡巍 | 一种高含氢量的饮用水的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1147304C (zh) | 用于腹膜透析或在连续肾替代疗法中置换的两部分形式的碳酸氢盐基溶液 | |
| KR101531479B1 (ko) | 의료용 재료로 사용하기 위한 고농도 콜라겐 제조방법 | |
| CN104649486B (zh) | 饮用水处理方法 | |
| CN107032519A (zh) | 富含微量元素的矿物质浓缩液及其制备方法和应用 | |
| US20050031708A1 (en) | Composition comprising a zeolite compound for treatment of diseases | |
| CN1280481A (zh) | 药用溶液的多隔间容器 | |
| CN103539252B (zh) | 生物联合光催化复合降解液态体系及其制备方法 | |
| JP2009027957A (ja) | 体内浄化用清涼飲料水および体内浄化用清涼飲料水の製造方法 | |
| CN104045121A (zh) | 小分子水制备及应用方法 | |
| JP2006063040A (ja) | 高浸透性を有する生理活性水の製造法 | |
| CN106890202A (zh) | 马齿苋提取物溶液及其制备方法 | |
| JP4040077B1 (ja) | 飲料水の製造方法及び装置 | |
| CN100347096C (zh) | 声光杀菌饮用水处理装置 | |
| CN201245487Y (zh) | 适宜饮水机桶装水使用的复合矿物活化矿化袋 | |
| JPH0998767A (ja) | アルコール性飲料からのアルコール除去方法、およびそれによって得られた低アルコール性飲料 | |
| CN1344690A (zh) | 健康净水的处理方法及其处理装置 | |
| KR100853205B1 (ko) | 고농도의 바나듐을 함유한 음용수의 제조 방법 및 이를위한 장치 | |
| CN206173314U (zh) | 一种环保节能黄酒杀菌装置 | |
| CN101757029A (zh) | 一种从牛脾脏中提取转移因子的方法 | |
| TW201806877A (zh) | 一種高鎂含量濃縮液及高鎂含量飲用水的混合系統 | |
| CN105796484A (zh) | 一种炎琥宁注射液及其制备方法 | |
| CN104845783A (zh) | 一种调理心肺功能的多糖啤酒及其制备工艺 | |
| JP6210509B2 (ja) | 密閉容器入り清涼飲料水の製造方法 | |
| KR20100093719A (ko) | 수액음료의 제조방법 | |
| CN87100543A (zh) | 利用麦饭石制备低度白酒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060324 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20060324 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20060426 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060428 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060428 |
|
| A072 | Dismissal of procedure |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20060822 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060823 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060823 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061010 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061113 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061212 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070207 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070207 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070320 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070413 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070518 |
|
| A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20070608 |